Nordic Nanovector completes patient enrolment into Phase 1 trial of Betalutin® in Diffuse Large B Cell Lymphoma ...Middle East

OSLO, Norway, Dec. 1, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that it has completed enrolment into the LYMRIT 37-05 Phase 1 clinical trial of Betalutin® (177Lu lilotomab satetraxetan) in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)...

Read More Details
Finally We wish PressBee provided you with enough information of ( Nordic Nanovector completes patient enrolment into Phase 1 trial of Betalutin® in Diffuse Large B Cell Lymphoma )

Also on site :

• Owen and Luke Wilson Share Rare Red Carpet Moment at 'Stick' Premiere
• Pentagon employee arrested for trying to leak secrets over Trump grievances
• Horrific bus crash: 22 workers injured in Sadat City rollover